suramin has been researched along with Thyroid Neoplasms in 2 studies
Suramin: A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties.
suramin : A member of the class of phenylureas that is urea in which each of the amino groups has been substituted by a 3-({2-methyl-5-[(4,6,8-trisulfo-1-naphthyl)carbamoyl]phenyl}carbamoyl)phenyl group. An activator of both the rabbit skeletal muscle RyR1 and sheep cardiac RyR2 isoform ryanodine receptor channels, it has been used for the treatment of human African trypanosomiasis for over 100 years.
Thyroid Neoplasms: Tumors or cancer of the THYROID GLAND.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergström, JD | 1 |
| Westermark, B | 1 |
| Heldin, NE | 1 |
| Trieb, K | 1 |
| Dorfinger, K | 1 |
| Neuhold, N | 1 |
| Selzer, E | 1 |
| Wilfing, A | 1 |
| Czernin, S | 1 |
| Hermann, M | 1 |
| Niederle, B | 1 |
| Gessl, A | 1 |
| Vierhapper, H | 1 |
2 other studies available for suramin and Thyroid Neoplasms
| Article | Year |
|---|---|
Epidermal growth factor receptor signaling activates met in human anaplastic thyroid carcinoma cells.
Topics: Antineoplastic Agents; Butadienes; Carcinoma; Enzyme Inhibitors; ErbB Receptors; Gene Expression Reg | 2000 |
Suramin affects differentiated and undifferentiated human thyroid epithelial cells in vitro.
Topics: Adenylyl Cyclases; Carcinoma; Carcinoma, Papillary; Cell Adhesion Molecules; Cell Differentiation; C | 1992 |